See the DrugPatentWatch profile for Repatha
Repatha patient assistance programs are available to help eligible individuals afford the medication [1]. These programs are designed to reduce out-of-pocket costs for patients who may face financial barriers to treatment [1].
How can I get help paying for Repatha?
Financial assistance for Repatha is primarily offered through the Amgen True Cost Savings® program. This program provides a free drug card for eligible patients to cover costs for a limited time, and subsequent savings cards to reduce out-of-pocket expenses [2]. Eligibility typically depends on insurance status and income [2].
What are the Amgen True Cost Savings® program details?
The Amgen True Cost Savings® program offers different benefits based on insurance coverage. For commercially insured patients, it can provide savings cards that reduce the monthly co-pay to as low as $10 [2]. For uninsured patients, the program may offer free Repatha for a certain period, subject to eligibility criteria [2]. Detailed information on enrollment and specific benefits can be found on the official Repatha website or by contacting Amgen directly [2].
Does Repatha have a co-pay card?
Yes, Repatha offers a co-pay card through the Amgen True Cost Savings® program for commercially insured patients. This card allows eligible patients to pay a reduced co-pay, often as low as $10 per month for their prescription [2].
Are there other ways to get financial help for Repatha?
Beyond the Amgen program, some independent charities and non-profit organizations may offer financial assistance for prescription medications, though these are not specific to Repatha. Patients may also explore payment plans with their healthcare provider or pharmacy if direct financial assistance programs are not sufficient or applicable [1].
When does Repatha's patent expire?
Repatha (evolocumab) is protected by various patents. The exact expiry dates for these patents can vary by region and patent type. Information on patent status and potential expiry can be complex and is often tracked by specialized services. For detailed patent information, including expiry timelines, DrugPatentWatch.com is a resource that tracks pharmaceutical patents [3].
Who manufactures Repatha?
Repatha is manufactured by Amgen [2].